Pilocarpine as a treatment option for dupilumab-related eye manifestations

Pilocarpine as a treatment option for dupilumab-related eye manifestations

Bibliographic Details
Main Authors:	Won Seok Roh, MD, Joo Hee Lee, MD, Su Min Kim, MD, Hyeong Ju Byeon, MD, Chang Ook Park, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	JAAD International
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666328722000773

Similar Items

Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
by: Nicholas A. Trum, BS, et al.
Published: (2021-08-01)

Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023-06-01)

Dupilumab for cancer-associated refractory pruritus
by: Aviv Talmon, MD, et al.
Published: (2023-08-01)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
by: Jonathan J. Park, PhD, et al.
Published: (2023-07-01)

Exacerbation of IgA nephropathy in a patient receiving dupilumab
by: Masako Yamamoto, MD, et al.
Published: (2022-03-01)

Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, MD, et al.
Published: (2025-05-01)

Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome
by: Xiaoman Du, MD, et al.
Published: (2022-11-01)

Treatment of lichen sclerosus and hypertrophic scars with dupilumab
by: Danielle M. Peterson, MD, et al.
Published: (2022-05-01)

Tumors in the setting of dupilumab use: A review of the literature
by: Shumeng Guo, et al.
Published: (2025-01-01)

Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
by: Albert E. Zhou, MD, PhD, et al.
Published: (2022-11-01)

Dupilumab-induced erythema nodosum
by: Danielle E. Mustin, MEng, et al.
Published: (2022-01-01)

Pemphigoid gestationis treated with dupilumab
by: Rita E. Chen, BA, et al.
Published: (2023-11-01)

Granulomatous hyperinflammatory state induced by dupilumab treatment for eosinophilic esophagitis
by: Kanak V. Kennedy, MD, et al.
Published: (2024-11-01)

Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab
by: Katelyn Singh, MD, et al.
Published: (2024-07-01)

Pyoderma gangrenosum developing in a patient treated with dupilumab
by: Jessica Nasseh, MD, et al.
Published: (2022-02-01)

Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab
by: Rémi Strizzolo, MD, et al.
Published: (2024-07-01)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
by: Christina Jiang, BS, MS, et al.
Published: (2023-12-01)

Resolution of dupilumab-associated alopecia areata with dosage modification
by: Maansi Kulkarni, BS, et al.
Published: (2022-04-01)

Dupilumab-induced pityriasis rosea
by: Morgan Zabel, BS, et al.
Published: (2023-03-01)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021-04-01)

De novo case of lichenoid eruption following dupilumab treatment
by: Tae-Eun Kim, MD, et al.
Published: (2021-07-01)

Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series
by: Shuhei Hara, MD, et al.
Published: (2023-05-01)

The Neuroprotective Effect of Bacopa monnieri against Pilocarpine Induced Status Epilepticus in Rats
by: Thanaporn Semphuet, et al.
Published: (2017-11-01)

Did dupilumab unmask smoldering mycosis fungoides?
by: Michelle Toker, BS, et al.
Published: (2023-08-01)

Dupilumab in HIV-positive patients: A case series report of 4 patients
by: Ameen Alawadhi, MD, et al.
Published: (2020-12-01)

Pattern Electroretinogram in Ocular Hypertension, Glaucoma Suspect and Early Manifest Glaucoma Eyes
by: Gabriele Gallo Afflitto, MD, et al.
Published: (2023-12-01)

Long-term effects of dupilumab on chronic rhinosinusitis with nasal polyps: A step towards clinical remission
by: Mona Al-Ahmad, MD, FRCPC, et al.
Published: (2025-02-01)

Introduction of self-injection increases compliance with dupilumab administration in adult patients with atopic dermatitis: A single-center retrospective study
by: Makoto Ito, MD, et al.
Published: (2020-12-01)

Drug-induced interstitial lung disease associated with dupilumab for the treatment of atopic dermatitis
by: Bethany F. Wilken, MSc, et al.
Published: (2024-08-01)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021-01-01)

A rare case of aggressive cytotoxic T-cell lymphoma in a patient on dupilumab
by: Renat Ahatov, BSA, et al.
Published: (2022-06-01)

A retrospective multicenter case series of real-world tralokinumab use in dupilumab-experienced patients
by: Edward I. Herman, MD, PhD, et al.
Published: (2024-04-01)

Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis
by: Makiko Kido-Nakahara, MD, et al.
Published: (2024-11-01)

Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab
by: Zi-Yi Choo, BS, et al.
Published: (2023-03-01)

Eczematous liraglutide eruption managed by dupilumab: A case report
by: Claudia Paganini, MD, et al.
Published: (2024-11-01)

Recalcitrant palmoplantar pustulosis controlled with dupilumab
by: Hannah D. Smith, BA, et al.
Published: (2023-05-01)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
by: Neda Shahriari, MD, et al.
Published: (2023-03-01)

Refractory eczematous dermatitis arising after allogeneic hematopoietic stem cell transplantation responsive to dupilumab
by: Jenny Lai, PhD, et al.
Published: (2024-11-01)

Dupilumab, incontinentia pigmenti, and alopecia: A serendipitous observation
by: Ashley Torkan Zilberstein, MD, et al.
Published: (2022-11-01)

Dupilumab improved atopic dermatitis without aggravating tuberculous eosinophilic pleural effusion in hyperimmunoglobulin-E syndrome
by: Piyaporn Chokevittaya, MD, et al.
Published: (2024-06-01)